NS-089/NCNP-02-201

· NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NS-089/NCNP-02-201, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]